Resmed dans l'actualité
Dispositifs médicaux pour maladies chroniques
Tamtam a trouvé 20 articles récents sur Resmed.
- ResMed CEO Michael J. Farrell Vests 48,136 Performance-Based Shares in November 2026
- Form 4 RESMED INC For: Nov 19 Filed by: Drexler Karen
- Form 4 RESMED INC For: Nov 19 Filed by: De Witte Jan
- Is This the Right Time to Hold Resmed Stock in Your Portfolio?
- Form 4 RESMED INC For: Nov 19 Filed by: Leong Justin
- How Resmed Inc. (RMD) Affects Rotational Strategy Timing
- ResMed director Ronald Taylor retires from board
- Three years of results could put ResMed (RMD) executives at twice their FY2027 stock award targets.
- Is At Home Sleep Testing Altering The Investment Case For ResMed (RMD)?
- ResMed Board Reduced to Ten Directors After Ronald Taylor Retirement at November 2026 Annual Meeting
- Why Are ResMed (ASX:RMD), Commonwealth Bank and BHP Blue Chips in Focus?
- FDA puts gastric implants on device shortages list, adds Resmed product discontinuation
- ResMed director Jan De Witte sells $101,673 of common stock By Investing.com
- ResMed (RMD) director plans to sell 429 shares acquired through stock vesting.
- ResMed Inc. (ASX:RMD): How Do FY27 First-Quarter Results Compare With Its Annual Outlook?
- ResMed (ASX:RMD) vs Pro Medicus (ASX:PME): Health Rally Twist
- ResMed (ASX:RMD) Margin Expansion Puts the Spotlight Back on Profit
- Resmed (ASX:RMD): What Do September-Quarter Earnings and FY27 Guidance Show?
- ResMed Share Price: A$35.20, Up 0.69% Nov 16
- ResMed (RMD), Why Is The Sleep Health Leader Back In Focus?
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme Resmed ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires